NUDT1 and cancer: Following this, ours and other laboratories developed MTH1 inhibitors demonstrating potent anticancer activity [11, 23], generating a broad interest in this protein as an anticancer target, which has resulted in several series of MTH1 inhibitors with differing abilities to kill cancer cells (discussed further in Section 2.3).